(Q40616259)
Statements
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial (English)
Curiel DT
1 reference
Alvarez RD
Barnes MN
Gomez-Navarro J
Wang M
Strong TV
Arafat W
Arani RB
Johnson MR
Roberts BL
Siegal GP